Resound Nexia vs Sony CRE-C20

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earned a SoundScore of 4.0/5 and an A grade, ranking #28 of 39 prescription hearing aids tested. The Nexia demonstrates clear strengths in specific areas. Feedback handling is excellent at 5.0/5, scoring 0.28 points above the category average—users can expect stable performance without whistling during typical daily activities. Own-voice comfort also stands out at 3.6/5, a solid score that sits 0.90 points above average, suggesting wearers may find their own voice sounds more natural compared to many competitors. However, speech performance presents a more mixed picture. Speech in quiet measures 3.2/5—solid in absolute terms but 0.19 points below the category average. More notably, speech in noise scores just 1.0/5, falling 1.11 points below average. This represents a significant limitation for users who frequently encounter challenging listening environments like restaurants or group conversations. Music streaming scores 2.8/5, essentially matching the category average. At this price point, several alternatives deliver stronger overall performance. The Phonak Sphere Infinio, Oticon Intent, and Oticon Real all score notably higher while occupying the same premium tier. Budget-conscious buyers might also consider options like the Jabra Enhance Select 500 at a lower price point with competitive sound quality. The Nexia may be best suited for users who prioritize feedback stability and own-voice comfort over speech-in-noise performance.

The Sony CRE-C20 is a mid-priced OTC hearing aid with an invisible-in-ear design, available for $999. In our lab testing, it earned a B grade with a SoundScore of 3.5/5, ranking #37 of 65 OTC hearing aids tested. This device shows a notable split in performance. Speech clarity is a clear strength—speech in quiet scores 4.1/5, which is 1.33 points above the category average, and speech in noise scores 2.7/5, sitting 1.24 points above average despite being only mixed in absolute terms. These results suggest the CRE-C20 prioritizes conversational intelligibility in its tuning approach. However, the device has significant limitations. Music streaming scored 0.0/5, falling 1.92 points below the category average—a notable weakness for users who want to stream audio. Feedback handling is solid at 3.9/5, though it sits 0.64 points below the category average of 4.54/5. Own voice comfort is mixed at 2.9/5, slightly above the category average. The CRE-C20 responds well to adjustment, with the normalized score improving from 3.3/5 at initial fit to 4.2/5 when tuned—a 0.9-point gain. Buyers focused primarily on speech understanding in conversations may find value here, but those wanting music streaming or seeking the strongest overall OTC performance should note that several competitors in this price range, including the Sony CRE-E10 at 4.66/5, scored higher in our testing.